Jones Financial Companies
CPRX

Jones Financial Companies’s Catalyst Pharmaceutical CPRX Stock Holding History

Jones Financial Companies’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$274K Buy
8,693
+2,617
+43% +$77.2K ﹤0.01% 2450
2026
Q1 		$142K Buy
6,076
+482
+9% +$11.5K ﹤0.01% 2527
2025
Q4 		$131K Buy
5,594
+1,533
+38% +$34.1K ﹤0.01% 2113
2025
Q3 		$79.3K Buy
4,061
+498
+14% +$10.2K ﹤0.01% 2173
2025
Q2 		$77.6K Buy
3,563
+890
+33% +$21K ﹤0.01% 2043
2025
Q1 		$66K Buy
2,673
+1,718
+180% +$38.7K ﹤0.01% 1948
2024
Q4 		$19.9K Buy
955
+255
+36% +$5.48K ﹤0.01% 2265
2024
Q3 		$13.7K Buy
700
+200
+40% +$3.71K ﹤0.01% 2091
2024
Q2 		$7.75K Buy
+500
New +$7.78K ﹤0.01% 1835

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jones Financial Companies's CPRX Position: Q2 2026 in Review

Jones Financial Companies increased its Catalyst Pharmaceutical (CPRX) stake by 43% in Q2 2026, buying an estimated $77.2K and bringing the position to 8,693 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #2450.

Jones Financial Companies first reported a position in CPRX in Q2 2024 and has held it in 9 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Jones Financial Companies held 8,693 shares of Catalyst Pharmaceutical worth $274K as of Q2 2026.
  • Jones Financial Companies bought 2,617 Catalyst Pharmaceutical shares in Q2 2026, an estimated $77.2K.
  • Catalyst Pharmaceutical made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #2450 holding.
  • Jones Financial Companies first reported a position in Catalyst Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
  • 396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.